| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM197007022830103 |
| P698 | PubMed publication ID | 4315902 |
| P2093 | author name string | Mizutani S | |
| West CD | |||
| Jubiz W | |||
| Meikle AW | |||
| Tyler FH | |||
| Levinson RA | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenytoin | Q410400 |
| dexamethasone | Q422252 | ||
| P304 | page(s) | 11-14 | |
| P577 | publication date | 1970-07-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Effect of diphenylhydantoin on the metabolism of dexamethasone | |
| P478 | volume | 283 |
| Q51039335 | Addisonian crisis in a dog treated with phenobarbitone. |
| Q40454665 | Advances in the diagnosis and treatment of Cushing's syndrome. |
| Q39274551 | Alterations of Glucocorticoid Actions by Other Drugs and Disease States |
| Q40142216 | Anticonvulsant drugs. An update |
| Q40780187 | Antiepileptic drugs. A review of clinically significant drug interactions. |
| Q67472008 | Barbiturate and anticonvulsant treatment in relation to osteomalacia with haemodialysis and renal transplantation |
| Q71684277 | Bioavailability of oral dexamethasone during high dose steroid therapy in neurological patients |
| Q40612852 | Bone complications of anticonvulsants |
| Q52490830 | Changes in the velocity of drug catabolism and their importance in drug therapy |
| Q36522161 | Chronic Antiepileptic Toxicity: A Review |
| Q48189200 | Cimetidine-induced brainstem dysfunction |
| Q40084496 | Clinical Implications of Enzyme Induction and Enzyme Inhibition |
| Q37920931 | Clinically relevant anti-epileptic drug interactions |
| Q33620352 | Cortisol production during high dose dexamethasone therapy in neurological and neurosurgical patients |
| Q39326605 | Cushing syndrome: current concepts of diagnosis and therapy. |
| Q34584934 | Cushing's syndrome in children and adolescents: current diagnostic and therapeutic strategies |
| Q38007987 | Cushing's syndrome: A review of diagnostic tests |
| Q70356786 | Disposition of total and unbound prednisolone in renal transplant patients receiving anticonvulsants |
| Q69357638 | Drug interactions |
| Q40300215 | Drug interactions with phenytoin |
| Q40472425 | Drug-Induced Metabolic Bone Disease |
| Q40291073 | Drug-induced disorders of vitamin D and mineral metabolism |
| Q44802694 | Effect of Diphenylhydantoin on Dexamethasone Suppression of Plasma Cortisol in Primary Open-Angle Glaucoma |
| Q46560194 | Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. |
| Q51668860 | Effect of diphenylhydantoin on patterns of insulin secretion in obese subjects |
| Q70767376 | Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics |
| Q40120350 | Effects of some clinically encountered drugs on steroid synthesis and degradation |
| Q69812633 | Enzyme induction and man |
| Q69732472 | Enzyme induction and medical treatment |
| Q44543538 | Extrarenal effects of furosemide on distribution of salt and water: an indirect mechanism of the drug's action? |
| Q70825468 | Influence of phenylbutazone, mofebutazone and aspirin on the pharmacokinetics of dexamethasone in the rat |
| Q36434754 | Intravenous prednisolone in chronic bronchial asthma |
| Q44132869 | Metabolic Interactions Among Environmental Chemicals and Drugs |
| Q40314648 | Neuroendocrine disorders and psychopathology. |
| Q37909318 | Pharmacokinetic drug interactions with phenytoin (Part II). |
| Q40329711 | Pharmacokinetic interactions with antiepileptic drugs |
| Q40284505 | Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review |
| Q34495396 | Phenobarbital-induced alterations in vitamin D metabolism |
| Q33620358 | Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients |
| Q66698589 | Phenytoin/dexamethasone interaction: A clinical problem |
| Q69472981 | Plasma Cortisol Suppression in Glaucoma |
| Q34585278 | Recent progress in epilepsy. Diagnostic procedures and treatment |
| Q66904991 | The adverse effect of anticonvulsant therapy on renal allograft survival. A preliminary report |
| Q43609922 | The effect of anticonvulsants on the dexamethasone suppression test |
| Q43950464 | The effects of ephedrine and theophylline on dexamethasone metabolism in bronchial asthma |
| Q71961776 | The effects of therapy with rifampicin and isoniazid on basic investigations for Cushing's syndrome |
| Q40922541 | The hypothalamic-pituitary-adrenal axis in obesity |
| Q66936270 | The metabolism of dexamethasone in the rat—Effect of phenytoin |
| Q68884943 | Transsphenoidal surgery for Cushing's syndrome |
| Q69570339 | Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients |
| Q68890991 | [Factors interfering with the dexamethasone suppression test] |
Search more.